Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenograstim PK/PD for Stem Cell Mobilization in Multiple Myeloma
NCT02184897Unknown
- Sponsor
- Asan Medical Center
- Start
- Jul 2014
- Primary completion
- Aug 2016
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Randomised, open-label trial of lenograstim in multiple myeloma (MM) (2 arms), sponsored by Asan Medical Center. Primary endpoint: Pharmacokinetic data of lenograstim. Status: unknown.
02
Drugs
lenograstim
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02184897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02184897.